auranofin [ s-triethylphosphine gold-2,3,4,6 tetra-o-acetyl-l-thio-beta-d-glucopyranoside ) sk & f 39162 ) has been administered at 0.1-0.25 mg/kg/day as the sole remission-inducing drug to 46 children affected with juvenile chronic arthritis ( jca ) .
C0039644
tetra
C0008059
children